(Q39414103)

English

Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5A replication complex inhibitor, BMS-790052.

scientific article published on June 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 September 2017

Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5A replication complex inhibitor, BMS-790052. (English)

1 reference

Europe PubMed Central

11 September 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jin-Hua Sun

1

1 reference

Europe PubMed Central

11 September 2017

Donald R O'Boyle Ii

2

1 reference

Europe PubMed Central

11 September 2017

Yan Zhang

3

1 reference

Europe PubMed Central

11 September 2017

Chunfu Wang

4

1 reference

Europe PubMed Central

11 September 2017

Peter Nower

5

1 reference

Europe PubMed Central

11 September 2017

Lourdes Valera

6

1 reference

Europe PubMed Central

11 September 2017

Susan Roberts

7

1 reference

Europe PubMed Central

11 September 2017

Richard E Nettles

8

1 reference

Europe PubMed Central

11 September 2017

Robert A Fridell

9

1 reference

Europe PubMed Central

11 September 2017

Min Gao

10

1 reference

Europe PubMed Central

11 September 2017

language of work or name

0 references

publication date

1 June 2012

1 reference

Europe PubMed Central

11 September 2017

1 reference

Europe PubMed Central

11 September 2017

55

1 reference

Europe PubMed Central

11 September 2017

6

1 reference

Europe PubMed Central

11 September 2017

1692-1699

1 reference

Europe PubMed Central

11 September 2017

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Viral heterogeneity of the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Telaprevir for previously untreated chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Hepatitis C virus proteins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Hepatitis C virus NS5A: tales of a promiscuous protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in humans: in vitro and in vivo correlations.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Replication-competent chimeric hepatitis C virus subgenomic replicons

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Distinct functions of NS5A in hepatitis C virus RNA replication uncovered by studies with the NS5A inhibitor BMS-790052

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25581

21 January 2018

Identifiers

10.1002/HEP.25581

1 reference

Europe PubMed Central

11 September 2017

1 reference

Europe PubMed Central

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39414103&oldid=1540342593"